Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

228.20 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9
...
88 89 Next >
VIX Roars Back: Trade Tensions Ignite "Fear Gauge," Signaling Potential Market Shift
The financial markets were gripped by a sudden wave of apprehension this past week as the Cboe Volatility Index (VIX), often dubbed the "fear gauge," experienced its most significant single-day surge... 
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs
AbbVie Stock Rises After FDA Approves Changed Recommendations For Use Of Popular Rinvoq Drug
In the second quarter, Rinvoq was the second most revenue-generating drug from AbbVie’s portfolio after Skyrizi. 
Via Stocktwits
2 Dividend Stocks to Double Up on Right Now
These two companies can help you sleep easy at night. 
Via The Motley Fool
Topics Economy Intellectual Property World Trade
What Does the Market Think About AbbVie Inc?
 
Via Benzinga
iShares CUD: Navigating the Nuances of Dividend Growth in a Dynamic Market
As the closing bell rings on October 10, 2025, the iShares US Dividend Growers Index ETF (CAD-Hedged) (TSX: CUD) stands as a crucial barometer for Canadian income investors seeking exposure to... 
Via MarketMinute
Topics Bonds ETFs Economy
JPMorgan Elevates Incyte Price Target Amidst Robust Pipeline and Commercial Success, Yet Maintains Cautious "Neutral" Stance
JPMorgan Chase & Co. (NYSE: JPM) has recently recalibrated its outlook on the biopharmaceutical giant Incyte Corporation (NASDAQ: INCY), with a notable upward revision of its price target for the... 
Via MarketMinute
Topics Economy Intellectual Property
Pfizer (NYSE:PFE) Marks 348th Consecutive Dividend Payment: A Pillar of Stability Amidst Transformation
New York, NY – October 9, 2025 – Pfizer Inc. (NYSE:PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Pfizer's 348th Consecutive Dividend: A Beacon of Stability Amidst Industry Headwinds
New York, NY – October 9, 2025 – Pfizer Inc. (NYSE: PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of... 
Via MarketMinute
Topics Economy Intellectual Property Retirement
Carolina Wealth Trims It's AbbVie Stake to Nearly Nothing
Via The Motley Fool
Topics Government World Trade
A Congress Member Sold Up To $300K In A.O. Smith Stock: Here's What You Need To Know
 
Via Benzinga
Why AbbVie and Johnson & Johnson Could Outperform Pfizer
Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential 
Via MarketBeat
Why AbbVie Stock Soared in September
It was a month stuffed with several different kinds of wins for the pharmaceutical company. 
Via The Motley Fool
Topics Regulatory Compliance
Healthcare Sector Defies Broader Market Swings, Leads S&P 500 Momentum on October 7, 2025
On a day where the broader S&P 500 and Nasdaq Composite indices soared to new all-time record highs, the S&P 500 Healthcare sector presented a compelling, albeit nuanced, narrative of market leadership... 
Via MarketMinute
Topics Artificial Intelligence ETFs Intellectual Property
Red Spruce Capital Dumps 35K SouthState Bank (SSB) Shares Worth $3.2 Million
Via The Motley Fool
Topics Credit Cards Regulatory Compliance
3 Dividend Stocks to Double Up On Right Now
The time is right for buying more of these great dividend stocks. 
Via The Motley Fool
Topics Economy Energy
3 Exceptional Stocks to Build Long-Term Wealth
Discover three standout growth stocks with strong long-term potential, spanning space, retail, and biotech industries, poised for sustained investor returns 
Via MarketBeat
Topics Economy
AbbVie's Botox Shows Improvement In Movement Disorder Study
AbbVie's Phase 2 ELATE trial shows onabotulinumtoxinA improves tremor scores and meets all endpoints, offering a new option for essential tremor. 
Via Benzinga
St Louis Financial Loads Up on AbbVie (ABBV) With 14,600 Shares Buy
Via The Motley Fool
Topics Intellectual Property
2 Healthcare Stocks to Research Further and 1 Facing Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
These S&P500 stocks are gapping in today's session
Stay tuned for the market movements in the S&P500 index on Thursday. Check out the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
Why AbbVie Stock Cruised to an Almost 6% Gain Today
A new expansion project and a win for a peer pharmaceutical company were attracting investors to the shares. 
Via The Motley Fool
Topics Government World Trade
Healthcare Sector Defies Headwinds, Rallies on Wall Street Amidst Shutdown and Jobs Data
New York, NY – October 1, 2025 – In a surprising turn of events on Wall Street today, the healthcare sector emerged as the undisputed leader, shrugging off the dual anxieties of a U.S. government... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Why AbbVie (ABBV) Stock Is Trading Up Today
Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 5.2% in the afternoon session after the company submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA)... 
Via StockStory
Topics Government World Trade
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
If you are looking for dividend stocks that can provide a reliable, long-term income stream, consider buying AbbVie, Coca-Cola, and Chevron. 
Via The Motley Fool
Topics Intellectual Property
U.S. Drug Pricing Reforms Send Ripples Across Global Healthcare Sector
The global healthcare sector is currently navigating a period of profound transformation, driven by aggressive regulatory changes emanating from the United States. As of late September 2025, a series... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a... 
Via MarketMinute
Topics Government
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing... 
Via MarketMinute
Topics Economy Government World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
88 89 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.